Exero Medical, a Jersey City, NJ- and Or Yehuda, Israel-based company focused on early detection of post-operative complications using tissue healing data, raised $12.7M in funding.
Backers included Longevity Venture Partners, Tech Council Ventures, and Edge Medical Ventures, alongside participation from existing investors.
The company intends to use the funds to expand operations and its development efforts.
Exero Medical aims to empower health care providers with actionable post-operative tissue healing data that can save lives, improve prognosis, and reduce cost of care. Its flagship product, the xBar system, uses sensors placed at the surgical site to collect data that can assist clinicians in early detection of major, life threatening complications after gastrointestinal surgery.
The company was founded in 2018 by MEDX Xelerator.
FinSMEs
13/02/2025